Literature DB >> 23647168

Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.

Traci C Green1, Sarah E Bowman, Nickolas D Zaller, Madeline Ray, Patricia Case, Robert Heimer.   

Abstract

Poisonings are the leading cause of adult injury death in the United States. Over 12 weeks in 2011, 143 key informant interviews were conducted using a structured interview guide in three study sites in New England. This analysis focuses on the 24 interviews with emergency department providers, substance use treatment providers, pain specialists, and generalist/family medicine practitioners. Using an iterative coding process, we analyzed statements regarding support and concern about naloxone prescription for pain patients and drug users. The study's implications and limitations are discussed and future research suggested. The Centers for Disease Control and Prevention funded this study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647168     DOI: 10.3109/10826084.2013.787099

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  17 in total

1.  Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.

Authors:  Tomás Barry; Jan Klimas; Helen Tobin; Mairead Egan; Gerard Bury
Journal:  Br J Gen Pract       Date:  2017-02-28       Impact factor: 5.386

2.  Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.

Authors:  Karla D Wagner; Lin Liu; Peter J Davidson; Jazmine Cuevas-Mota; Richard F Armenta; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

Review 3.  A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Authors:  Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

4.  Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial.

Authors:  Ingrid A Binswanger; Deborah Rinehart; Shane R Mueller; Komal J Narwaney; Melanie Stowell; Nicole Wagner; Stan Xu; Rebecca Hanratty; Josh Blum; Kevin McVaney; Jason M Glanz
Journal:  J Gen Intern Med       Date:  2022-02-07       Impact factor: 6.473

5.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

6.  Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians.

Authors:  Pamela Leece; Aaron Orkin; Rita Shahin; Leah S Steele
Journal:  Can Fam Physician       Date:  2015-06       Impact factor: 3.275

7.  "You can see those concentric rings going out": Emergency personnel's experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire.

Authors:  Elizabeth Saunders; Stephen A Metcalf; Olivia Walsh; Sarah K Moore; Andrea Meier; Bethany McLeman; Samantha Auty; Sarah Bessen; Lisa A Marsch
Journal:  Drug Alcohol Depend       Date:  2019-09-13       Impact factor: 4.852

8.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06

9.  Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.

Authors:  Mari-Lynn Drainoni; Elisa A Koppelman; James A Feldman; Alexander Y Walley; Patricia M Mitchell; Jacqueline Ellison; Edward Bernstein
Journal:  BMC Res Notes       Date:  2016-10-18

10.  'I have it just in case' - Naloxone access and changes in opioid use behaviours.

Authors:  Sarah Cercone Heavey; Yu-Ping Chang; Bonnie M Vest; R Lorraine Collins; William Wieczorek; Gregory G Homish
Journal:  Int J Drug Policy       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.